3/28
08:06 am
CLRB
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $12.00 price target on the stock, up previously from $11.00.
Medium
Report
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $12.00 price target on the stock, up previously from $11.00.
3/28
07:32 am
CLRB
Rating for CLRB
Medium
Report
Rating for CLRB
3/28
07:32 am
CLRB
Rating for CLRB
Medium
Report
Rating for CLRB